🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Aumolertinib is a third-generation epidermal growth factor receptor (EGFR) ...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2022-12-14
Trial ID
NCT05493501
This is an open-label and uncontrolled study to evaluate the comparative PK...
Status
Completed
Location
Spaulding Clinical Research
Start Date
2021-06-21
Trial ID
NCT04969965
Treatments Being Tested
This study is an open-label, multicenter Phase IB/II clinical trial to eval...
Status
Unknown
Location
Multiple Locations
Start Date
2023-10
Trial ID
NCT06092268
HS-20117 is a fully-human EGFR-MET immunoglobulin G1(IgG1)-like bispecific ...
Status
Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2024-05-28
Trial ID
NCT06417008
Treatments Being Tested
Participants aged 18 to 75 years with severe hepatic impairment (Child-Pugh...
Status
Completed
Location
American Institute Research
Start Date
2022-03-30
Trial ID
NCT05199610
Treatments Being Tested
Objective:Patients with asymptomatic or minimally symptomatic Stage IV EGFR...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2023-01-01
Trial ID
NCT05800223
Treatments Being Tested
This is a Phase Ib study to evaluate the safety, tolerability, and efficacy...
Status
Not Yet Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2024-09
Trial ID
NCT06585059
Treatments Being Tested
Efficacy and safety of postoperative adjuvant treatment of NSCLC patients w...
Status
Unknown
Location
Shanghai Chest Hospital
Start Date
2022-01-14
Trial ID
NCT04922138
Treatments Being Tested
This is a Phase 1, open-label, multicenter, multiple-dose study to evaluate...
Status
Recruiting
Location
Republika Srpska University Clinical Centre of the Republic of Srpska, Dvanaest beba bb
Start Date
2024-12-05
Trial ID
NCT07130916
Treatments Being Tested
This study is a prospective, multicenter, single arm clinical study. Thirty...
Status
Recruiting
Location
First Affiliated Hospital of Kunming University
Start Date
2023-10-30
Trial ID
NCT06102928
Treatments Being Tested